| 期 |
标题 |
文件 |
| 编号 4 (2017) |
Platelet-leukocyte aggregates in the circulating blood as an early indicator of recurrence of chronic obstructive pyelonephritis |
|
|
Barinov E., Grigoryan K., Balykina A., Faber T.
|
| 卷 13, 编号 3 (2021) |
Thrombocytosis as a cause of thrombohemorrhagic complications in the practice of a nephrologiste |
|
|
Mikhailova Z., Cherepanova V.
|
| 编号 6 (2013) |
Lung artery thromboembolism in young patient with severe Wegener's granulomatosis in absence of traditional thrombotic risk factors |
|
|
Makarov E., Novikov P., Tareev E., Guliaev S., Nikiforova N., Parfenova S.
|
| 卷 16, 编号 2 (2024) |
Difficulties in diagnosis and treatment of atypical hemolytic-uremic syndrome: clinical case |
|
|
Bakhareva Y., Chapaeva N.
|
| 卷 15, 编号 4 (2023) |
Difficulties in diagnosing and treating recurrent aHUS in a modern hospital setting |
|
|
Popov S., Yesayan A., Guseynov R., Perepelitsa V., Vorobyova O., Sadovnikova A.
|
| 卷 15, 编号 2 (2023) |
Difficulties in diagnosing microscopic polyangiitis |
|
|
Simonova O., Postnikova G., Stolyarevich E.
|
| 编号 2 (2010) |
Difficulties in renal anemia treatment. Role of prolonged erythropoietin receptor activators |
|
|
Kozlovskaya L., Milovanov Y., Milovanova L., Dobrosmyslov I., Kozlovskaya L., Milovanov Y., Milovanova L., Dobrosmislov I.
|
| 编号 3 (2018) |
Difficulties in screening for protein-calorie deficiency in patients on program hemodialysis |
|
|
Yakovenko A., Rumyantsev A., Konyukhov E., Ryasnyansky V., Samokhvalova N.
|
| 编号 1 (2012) |
Tubulo-interstitial involvement in kidney disease in patients with infective endocarditis |
|
|
Ponomareva E., Tyapkina M., Rebrov A., Ponomareva E., Tiapkina M., Rebrov A.
|
| 编号 1 (2011) |
Renal tubulointerstium and it's involvement in arterial hypertension |
|
|
Arutyunov G., Oganezova L.
|
| 编号 1 (2012) |
SEVERE PODOCYTE DAMAGE IN ASYMPTOMATIC PATIENT WITH FABRY DISEASE |
|
|
Fomin V., Pulin A., Aksenova O., Kustova T., Girina S., Roshchupkina S., Kudryavtsev V., Varshavskiy V., Golitsyna E., Damulin I., Panasyuk V., Mukhin N., Fomin V., Pulin A., Aksenova O., Kustova T., Girina S., Roschupkina S., Kudravtsev V., Varshavskii V., Golitsina E., Damulin I., Panasiuk V., Mukhin N.
|
| 卷 12, 编号 3 (2020) |
Dear colleagues and readers! |
|
|
Kotenko O.
|
| 卷 11, 编号 3 (2019) |
Dear readers and colleagues! |
|
|
Rotenko O.
|
| 编号 2 (2009) |
Ultrasound scanning of kidney: opportunities and limitations |
|
|
Gendlin G., Ettinger O., Reznik E., Tronina O., Solomonova L., Gendlin G., Ettinger O., Resnyk E., Tronina O., Solomonova O.
|
| 编号 5-6 (2012) |
Mild cognitive disorders in chronic kidney disease: clinical spectrum, pathogenesis, risk factors, treatment |
|
|
Rogova I., Fomin V., Damulin I., Mukhin N.
|
| 编号 6 (2011) |
Serum and urinary interleukin-6 as a marker of activity of HCV-associated cryoglobulinemic nephritis: role in determination of efficacy of antiviral therapy in combination with rituximab |
|
|
Korotchaeva Y., Kozlovskaya L., Gordovskaya N., Speranskiy A., Milovanova S., Roshchupkina S.
|
| 编号 2 (2014) |
Dynamics of osteopontin levels during therapy with candesartan in patients on program hemodialysis |
|
|
Ovskaya E.
|
| 编号 6 (2014) |
Melatonin levels and markers of acute kidney injury in acute coronary syndrome |
|
|
Mikhailova Z., Shalenkova M., Klimkin P.
|
| 编号 1 (2016) |
Successful pregnancy in a patient with Fabry disease and predominant renal involvement |
|
|
Kirsanova T., Khoroshkeeva O., Kamyshova E., Sharashkina N., Tetruashvilli N.
|
| 编号 3 (2017) |
Successful treatment of massive hemoperitoneum after transcutaneous fine-needle puncture biopsy of the graft |
|
|
Yankovoy A., Sinyutin A., Stepanov V.
|
| 编号 6 (2014) |
Successful treatment of segmental mesenteric thrombosis in renal transplant recipient |
|
|
Yankovoy A., Zulkarnaev A., Sinyutin A., Stepanov V.
|
| 编号 3 (2018) |
Charter of the Metropolitan Association of Nephrologists |
|
|
- -.
|
| 卷 12, 编号 1 (2020) |
USTAV STOLIChNOY ASSOTsIATsII VRAChEY-NEFROLOGOV |
|
|
- -.
|
| 卷 11, 编号 3 (2019) |
USTAV STOLIChNOY ASSOTsIATsII VRAChEY-NEFROLOGOV |
|
|
- -.
|
| 卷 12, 编号 3 (2020) |
USTAV STOLIChNOY ASSOTsIATsII VRAChEY-NEFROLOGOV |
|
|
- -.
|
| 卷 15, 编号 1 (2023) |
Participation of fibroblast factor 23 in the development of acute myocardial infarction in patients with chronic kidney disease |
|
|
Mambetova A., Gaturaeva S., Semenova I.
|
| 编号 5 (2014) |
Fibroblast growth factor type 23 and chronic kidney disease |
|
|
Nimgirova A., Esayan A., Kayukov I.
|
| 编号 2 (2010) |
Von Willebrand Factor |
|
|
- -.
|
| 编号 1 (2019) |
Risk factors and prevention of multiple organ dysfunction syndrome (literature review) |
|
|
Nickolaev A., Filatova N.
|
| 编号 5 (2013) |
Chronic kidney disease: risk factors for development and progression |
|
|
Krupnova M., Bondarenko M., Marasaev V.
|
| 卷 13, 编号 3 (2021) |
Risk factors for development of severe hypocalciemia after paratyreoidectomy for secondary hyperparathyroidisis in dialysis patients |
|
|
Kislyy P., Parshina E., Zulkarnaev A., Tolkach A., Mikhailova S., Chernikov R., Zarya Y.
|
| 编号 3 (2011) |
Chronic kidney disease risk factors in development of renal dysfunction in chronic heart failure patients |
|
|
Kirshina N., Pimenov L.
|
| 编号 3 (2012) |
FAKTORY, SPOSOBSTVUYuShchIE UVELIChENIYu DISPERSII INTERVALA QT U PATsIENTOV, POLUChAYuShchIKh TERAPIYu PROGRAMMNYM GEMODIALIZOM I POSTOYaNNYM AMBULATORNYM PERITONEAL'NYM DIALIZOM |
|
|
Korelina A., Zhdanova T., Nazarov A.
|
| 编号 6 (2014) |
Pharmacoeconomic aspects of the treatment of anemia in russian patients with chronic kidney disease |
|
|
Ryazhenov V., Gorokhova S.
|
| 编号 2 (2010) |
Fibrillary glomerulonephritis / immunotactoid nephropathy |
|
|
- -.
|
| 编号 5 (2010) |
Fibrinolytic activity of the urine in patients with arterial hypertension with different efficacy of antihypertensive treatment |
|
|
Podorol'skaya L., Chumakova E., Lobanova E., Alekseeva L.
|
| 卷 11, 编号 3 (2019) |
Physiological basis for lithokinetic therapy |
|
|
Dutov V., Popov D., Rumyantsev A., Podoynitsyn A., Buymistr S., Bondarenko V., Goncharuk V., Dadashov M.
|
| 卷 12, 编号 2 (2020) |
Physiological basis for lithokinetic therapy. Part 2 |
|
|
Dutov V., Popov D., Dutov S., Rumyantsev A., Podoynitsyn A., Buymister S., Goncharuk V., Dadashov M.
|
| 卷 14, 编号 2 (2022) |
Physiology of non-diabetic glucosuria and its role in the recurrence of urinary tract infections: methods of correction |
|
|
Berdichevsky V., Zhmurov V., Sapozhenkova E., Romanova A., Rasulov F., Khilkevich S., Gonyaev A., Korabelnikov M.
|
| 编号 6 (2013) |
Herbal medications in combined treatment of urinary tract infections |
|
|
Popkov V., Blyumberg B., Osnovin O., Shatylko T.
|
| 编号 6 (2010) |
Phytotherapy with Canephron in nephrological practice: present and future |
|
|
Borisov V., Gordovskaya N., Shilov E.
|
| 编号 1 (2013) |
Phytotherapy of urate nephrolithyasis |
|
|
Blyumberg B., Osnovin O., Fomkin R.
|
| 编号 5 (2010) |
Focal segmental glomerulosclerosis: focus on cyclosporine |
|
|
Kozlovskaya L.
|
| 编号 6 (2010) |
DEVELOPMENT OF EARLY STAGES OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH OBESITY |
|
|
Gallyamov M., Severova M., Surkova O.
|
| 卷 15, 编号 3 (2023) |
Formulas for estimating glomerular filtration rate: correct and incorrect use |
|
|
Shilov E.
|
| 编号 3 (2011) |
Variants of renal osteodystrophy |
|
|
Milovanov Y., Milovanova L., Kozlovskaya L.
|
| 编号 1 (2014) |
Calcium-containing phosphatebinders |
|
|
- -.
|
| 卷 11, 编号 4 (2019) |
Calcium and phosphorus metabolism in children with neurogenic urination disorders |
|
|
Latyshev D., Lobanov Y., Zverev Y., Tekutyeva N., Mikheeva N.
|
| 编号 5 (2014) |
Fractional excretion of uric acid as an alternative marker of low natriuresis |
|
|
Arutyunov G., Dragunov D., Sokolova A., Arutyunov A.
|
| 编号 2 (2019) |
Functional activity of blood cells in chronic obstructive pyelonephritis |
|
|
Barinov E., Grigoryan K.
|
| 卷 14, 编号 1 (2022) |
The functional state of the kidneys and albuminuria in individuals with cardiovascular risk factors |
|
|
Mikhailova L., Shupina M., Safonova V., Butova V., Sheremet V.
|
| 编号 3 (2012) |
FUNKTsIONAL'NOE SOSTOYaNIE POChEK I KAL'TsIFIKATsIYa KLAPANNOGO APPARATA SERDTsA U ZhENShchIN V POSTMENOPAUZE |
|
|
Mukhin N., Alekseeva L., Babanin V., Dokina E., Minushkina L.
|
| 编号 1 (2017) |
Renal function and cardio-renal relationship in patients with primary hypothyroidism and concurrent arterial hypertension |
|
|
Nikolaeva A., Pimenov L.
|
| 编号 1 (2017) |
Renal function and some indicators of homeostasis in women with pregnancy complicated by pre-eclampsia |
|
|
Akhmedov F., Avakov V., Negmatullaeva M.
|
| 卷 12, 编号 4 (2020) |
Renal status, blood d-dimer and procalcitonin levels in COVID-19 |
|
|
Murkamilov I., Aitbaev K., Fomin V., Kudaibergenova I., Maanaev T., Murkamilova Z., Yusupov F.
|
| 编号 3 (2011) |
Opportunities of healthcare centers in detection of patients with kidney disease and cardiovascular risk |
|
|
Avdeeva M., Shcheglova L.
|
| 卷 12, 编号 3 (2020) |
Renal function and cytokine profile changes with COVID-19 |
|
|
Murkamilov I., Aitbaev K., Fomin V., Kudaibergenova I., Murkamilova Z., Yusupov F.
|
| 编号 3 (2011) |
CHOLESTEROL ATHEROEMBOLIC DISEASE - EMERGING VARIANT OF ACUTE KIDNEY INJURY |
|
|
- -.
|
| 卷 12, 编号 2 (2020) |
Chronic kidney disease in combination with chronic obstructive pulmonary disease under lowmountain conditions: risk factors, early detection and clinical and functional features |
|
|
Dolgalev D., Kaliev R.
|
| 编号 1 (2016) |
Chronic kidney disease and hyperparathyroidism: primary and/or secondary? (a case report) |
|
|
Vetchinnikova O., Britvin T., Gulimova S.
|
| 编号 6 (2010) |
CHRONIC KIDNEY DISEASE AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE |
|
|
Makeeva E., Troshen'kina O., Khiteva S.
|
| 编号 3 (2010) |
Chronic kidney disease and program of increase of life span in Russian Federation |
|
|
Shilov E., Kozlovskaya N., Bobkova I., Shvetsov M., Vatazin A., Shilov E., Kozlovskaya N., Bobkova I., Shvetsov M., Vatazin A.
|
| 编号 1 (2014) |
Chronic kidney disease and the aging population |
|
|
Tonelli M., Riella M.
|
| 编号 6 (2010) |
CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION |
|
|
Fomin V., Kiyakbaev G.
|
| 编号 3 (2017) |
Chronic kidney disease and cerebrovascular disorders: the role of cystatin C |
|
|
Murkamilov I., Fomin V., Aytbayev K., Rayimzhanov Z., Redzhapova N., Yusupov F., Aydarov Z.
|
| 编号 3 (2010) |
Chronic kidney disease in women |
|
|
Mukhin N., Moukhin N.
|
| 编号 1 (2015) |
Chronic kidney disease (CKD) in disadvantaged populations |
|
|
Garcia-Garcia G., Jha V.
|
| 卷 12, 编号 4 (2020) |
Chronic kidney disease in patients with impaired thyroid function |
|
|
Bolotova E., Dudnikova A., Kiyanitskaya I.
|
| 编号 3 (2014) |
Chronic kidney disease in elderly: diagnostic and management challenges |
|
|
Fomin V., Milovanov Y., Yu Milovanova L., Moisseev S., Moukhin N.
|
| 卷 14, 编号 1 (2022) |
Chronic Kidney Disease: Non-invasive Diagnosis of Chronic Renal Failure by Monochrome Nanoparticle Analysis |
|
|
Choi E.
|
| 编号 4 (2012) |
Khronicheskaya bolezn' pochek: osnovnye printsipy skrininga, diagnostiki, profilaktiki i podkhody k lecheniyu |
|
|
- -.
|
| 编号 1 (2010) |
CHRONIC PROGRESSIVE NEPHROPATHIES IN ELDERLY PATIENTS |
|
|
- -.
|
| 编号 3 (2012) |
KhRONIChESKIY GLOMERULONEFRIT I SERDEChNO-SOSUDISTAYa SISTEMA |
|
|
Murkamilov I., Kaliev R., Fomin V., Kaliev K., Ayypova D., Imanov B.
|
| 编号 3 (2010) |
Chronic glomerulonephritis: arguments for cyclosporine use |
|
|
Kozlovskaya L.
|
| 卷 15, 编号 1 (2023) |
Chronic dialysis in elderly and senile patients: survival and factors affecting outcome. Single-center experience |
|
|
Kurilovich K., Komissarov K., Krasko O.
|
| 卷 17, 编号 1 (2025) |
Chronic pyelonephritis as a mimics of kidney tuberculosis |
|
|
Kulchavenya E., Kholtobin D., Shevchenko S.
|
| 编号 1 (2017) |
Chronic kidney disease and atrial fibrillation |
|
|
Dyadik A., Yarovaya N., Suliman Y., Zborowskyy S., Merkurev V., Kugler T.
|
| 编号 1 (2012) |
Health centers: opportunities and perspectives in early diagnosis of heart failure and kidney involvement in patients with arterial hypertension |
|
|
Arutyunov G., Oganezova L., Sokolova A., Arutiunov G., Oganezova L., Sokolova A.
|
| 编号 2 (2013) |
Cystatin C and target organ damage in arterial hypertension |
|
|
Rebrov A., Kuklina A.
|
| 编号 2 (2017) |
Cytokine model of the development of cardiovascular complications in chronic kidney disease |
|
|
Murkamilov I., Fomin V., Aitbaev K., Rayimzhanov Z., Redzhapova N., Yusupov F., Aydarov Z.
|
| 卷 14, 编号 3 (2022) |
Cytokine profile and cardiovascular status in patients with chronic kidney disease after covid-19 |
|
|
Zhmurov D., Zhmurov V., Petrov I., Petelina T., Gapon L., Yaroslavskaya E., Petrova Y., Zhmurova E., Ermakova A., Ermakova P.
|
| 编号 4 (2018) |
Cytokines and arterial stiffness at the early stage of chronic kidney disease: the relationship and prognostic role |
|
|
Murkamilov I., Aitbaev K., Fomin V., Murkamilova Z., Sabirov I.
|
| 编号 1 (2009) |
Citoprotective effects of erythropoietin |
|
|
Zakharov Y.
|
| 编号 4 (2013) |
Frequency and predictors of acute kidney injury in patients after surgical correction of heart valve disease |
|
|
Iskenderov B., Sysina O.
|
| 编号 2 (2015) |
Percutaneous nephrolithotripsy for staghorn renal calculi of KN-1-3 degrees: pro et contra |
|
|
Podojnicyn A., Dutov V., Urenkov S., Ivanov A., Amosov N.
|
| 编号 1 (2010) |
SH.I. RATNER AND HIS ROLE IN THE STUDY OF HEMORRHAGIC FEVER WITH RENAL SYNDROME ON RUSSIAN EAST (TO 110-TH ANNIVERSARY OF HIS BIRTH) |
|
|
- -.
|
| 编号 1 (2019) |
The evolution of anemic syndrome against the background of chronic kidney disease in real clinical practice |
|
|
Korneeva S., Pribylov S., Bezgin A., Trigub A.
|
| 卷 16, 编号 2 (2024) |
Evolution of concepts about kidney functions and their role in the regulation of water and mineral metabolism |
|
|
Koroshchenko G., Subotyalova A., Aizman R., Subotyalov M.
|
| 卷 12, 编号 3 (2020) |
Ezetimibe in chronic kidney disease: an effect on the risk of developing cardiovascular and cerebral complications |
|
|
Murkamilov I., Sabirov L., Fomin V., Murkamilova Z., Yusupov F., Redzhapova N., Rayimzhanov Z.
|
| 卷 13, 编号 2 (2021) |
Economic evaluation of renal replacement therapy strategies in Moscow |
|
|
Antonov A., Bezdenezhnykh T., Trifonova A., Kotenko O., Omelyanovskiy V., Musina N.
|
| 编号 5 (2013) |
Phosphate-binder therapy: economical aspects |
|
|
Mikhailova N.
|
| 编号 2 (2011) |
Experimental models of renal tubulointersitial damade in arterial hypertension |
|
|
Arutyunov G., Sokolova A., Oganezova L.
|
| 编号 2 (2009) |
Experimental models of chronic nephropathies |
|
|
Paltseva E.
|
| 卷 14, 编号 2 (2022) |
Expert judgement «Correction of hyperkalemia in CKD. Modern possibilities and therapeutic relevance» |
|
|
Mikhailova N.
|
| 卷 14, 编号 3 (2022) |
Expert opinion. Low-protein high caloric enteral nutrition «Fresubin Renal» in nephrology |
|
|
Shutov E.
|
| 卷 14, 编号 2 (2022) |
Expert Council «Therapy of mineral and bone disorders in CKD. Sevelamer carbonate: from control of hyperphosphatemia to pleiotropic effects» |
|
|
- -.
|
| 编号 3 (2018) |
Extracorporeal membrane oxygenation in life-threatening ANCA-positive diffuse necrotizing alveolar hemorrhage |
|
|
Lysenko M., Frolova N., Ketskalo M., Dyakova E., Sysoeva I., Zhilinskaya T., Kotenko O., Volgina G.
|
| 卷 13, 编号 4 (2021) |
Endothelial dysfunction in patients with chronic kidney disease: prognostic potential of endothelin-1 |
|
|
Gasanov M., Panchenko M., Batyushin M., Bronovitskaya N., Razina A.
|
| 编号 2 (2018) |
Epigenetic regulation of renal fibrosis in diabetic nephropathy: focus on histone modifications |
|
|
Aitbaev K., Murkamilov I., Murkamilova Z., Fomin V.
|
| 卷 14, 编号 2 (2022) |
Epidemiology of covid-19 in patients on renal replacement therapy in the Russian federation in 2021 (brief report) |
|
|
Shilov E., Shilova M., Rumyantseva E., Yesayan A., Kotenko O.
|
| 801 - 900 的 915 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |
